[ad_1]
New cases of COVID-19 in PH reach 1,509, the total of cases reached 362,243
The Philippines records a total of 1,509 new cases of coronavirus disease (COVID-19) with a total of 362,243 cases, the Department of Health (DOH) reported on Wednesday (October 21).
The DOH also recorded 60 911 deaths and recoveries. The recoveries recorded for the day brought the total number to 311,506.
Based on DOH COVID-19 Case Bulletin No. 221, 90% of the total daily cases occurred in the last 14 days, while the main regions in the last two weeks are in the National Capital Region (NCR) with 320 cases and Region 4A with 297 cases.
The DOH also added that 41 duplicates were removed from the total case count. 31 recovered cases and three deaths have also been removed from the list.
The Octa research team from the University of the Philippines said there are still areas with high cases of COVID-19 as of Oct. 11, according to their research. These areas include various areas in the National Capital Region (NCR), Pasig, Makati, Pasay, Mandaluyong, and Marikina.
Meanwhile, DOH spokesman Usec. María Rosario Vergeire said that 60-70% of the country’s population should be vaccinated against COVID-19 for herd immunity.
“It doesn’t stop there because we would need to immunize 60-70% of the population in order to have herd immunity. So when we talk about P12.5 billion, that only covers our population, ”he said. CAA (with reports from Aiko Miguel)
DOH registers 2,502 new confirmed cases of COVID-19
Manila, Philippines – The Department of Health or DOH reported Sunday that the total number of cases of coronavirus disease (COVID-19) nationwide is now 339,341.
This, after 2,502 newly confirmed cases were added to the list of COVID-19 patients.
The DOH also announced 17,057 recoveries recorded as of 4 p.m. Sunday, bringing the total number of recoveries to 293,075.
In a warning, the department also said that of the 2,502 cases reported on Sunday, 2,106 (84%) occurred in the past 14 days (September 28 – October 11, 2020).
The top regions with cases in the past two weeks were NCR (650 or 31%), Region 4A (492 or 23%) and Region 3 (203 or 10%), according to the advisory.
Eighty-three (83) deaths were also recorded on Sunday, bringing the total deaths to 6,321.
The department also recorded 87 duplicates that were removed from the total case count. Of these, 35 were recovered cases.
It added that the 41 cases previously labeled as recovered were reclassified as deaths. – / mbmf
DOH, WHO encourages the public to access free online mental health courses
The Department of Health (DOH) and the World Health Organization (WHO) encourage the public to enroll in the free online course on mental health.
The QualityRights Mental Health Online Training Course was developed by WHO and translated into Filipino in partnership with DOH. Its goal is to improve access to quality social and mental health services.
Participants in the online course, according to the Department of Health, will be able to improve their own mental health, as well as support their friends and loved ones who are experiencing mental health problems.
Interested persons can register for free at http://bit.ly/QualityRightsPH.
Health Secretary Francisco T. Duque III hopes that the free online course can help address mental health conditions and cognitive disabilities in the country.
“Mental health is a major public health problem that must be openly discussed and addressed. With the e-learning modules translated into Filipino, we hope to educate more people and facilitate more discussions that will ultimately help us understand and address the need of Filipinos with mental health and other intellectual and cognitive disabilities, ”he said. . CAA
Avigan’s Clinical Trials at HP May Begin Next Week – DOH
Manila, Philippines – Clinical trials of the Avigan flu drug in the country may finally begin next week, the Department of Health (DOH) said.
The Undersecretary of Health, María Rosario Vergeire, said that the process for the clinical trial is currently being finalized, adding that the proponent of the research has been given the signal to recruit study participants.
Vergeire said a minor problem in the insurance documents just needed to be fixed before they could begin testing.
Merong minor comment on the name of the legal service for this insurance document. Iyon na lang, but we already gave the signal to the proponents, ”he said.
“Once we have recruited, hopefully by next week we will really start officially,” he added.
The clinical trial, which aims to analyze the potential benefits of the drug made in Japan for patients with coronavirus disease, will last nine months. Four hospitals will participate in the trial.
It was supposed to start in August, but was delayed due to some problems in the legal arrangements.
The Avigan tablets were delivered in early August by the Japanese government for the use of 100 patients. – RRD (with details of correspondent Aiko Miguel)
